Locally advanced breast cancer treated with primary chemotherapy: Comparison between magnetic resonance imaging and pathologic evaluation of residualdisease

Citation
G. Trecate et al., Locally advanced breast cancer treated with primary chemotherapy: Comparison between magnetic resonance imaging and pathologic evaluation of residualdisease, TUMORI, 85(4), 1999, pp. 220-228
Citations number
40
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
TUMORI
ISSN journal
03008916 → ACNP
Volume
85
Issue
4
Year of publication
1999
Pages
220 - 228
Database
ISI
SICI code
0300-8916(199907/08)85:4<220:LABCTW>2.0.ZU;2-1
Abstract
Aims and background: We evaluated the response of locally advanced breast c ancer to induction chemotherapy using MRI techniques. The size and vitality of any residual pathologic tissue was quantified by means of morphologic a nd dynamic analysis. A curve derived from the dynamic parameters shows the uptake intensity with respect to the time elapsed since administration, whi ch is related to vascularization and therefore indirectly reflects the angi ogenesis of malignant tissue. Methods and study design: A group of 30 patients were examined with MRI for staging purposes before undergoing treatment and subsequently to assess th e response to treatment. Alterations in size and dynamic parameters were cl osely monitored, Results: The overall accuracy was 90%, the sensitivity 96%, the specificity 75%, the positive predictive value 92.5% and the negative predictive value 66%. Interestingly, analysis of the dynamic curves made it possible to obt ain additional information regarding the angiogenetic activity of the resid ual tumor. Conclusions: Evaluation of the response to treatment by means of convention al imaging and clinical examination can be particularly difficult because o f the fibrosis induced by cytotoxic drugs or the small volume of residual d isease. The additional information supplied by MRI could therefore allow a more conservative surgical approach in selected cases of optimal response t o treatment, as well as a much more accurate follow-up. Furthermore, the va riation in dynamic parameters according to the vitality of residual disease could in the future become a useful tool for monitoring the effectiveness of antiangiogenetic drugs.